In the ASC setting, our group previously demonstrated that increased YKL-40 protein expression in ASC tumor cells was related to p53 overexpression/mutation (59), nodal involvement (34) and a worse patient prognosis in terms of OS and disease-free survival (59). This evidence concerns the gene CHI3L1 and neoplasm.